We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

94.08% of the stock is currently owned by institutional investors. United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of NASDAQ:NTLA opened at $9.30 on Thursday. The company has a market cap of $962.71 million, a P/E ratio of -1.71 and a beta of 1.97. Intellia Therapeutics, Inc. has a 52 week low of $8.30 ...

BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm thinks the challenges to owning United in 2025 are ...

SILEXION THERAPEUTICS CORP CONSOLIDATED STATEMENTS OF OPERATIONS (U.S. dollars in thousands, except share data) Year ended December 31 2024 2023 OPERATING EXPENSES: Research and development ...

What is the current share price of United Therapeutics Corp (UTHR)? United Therapeutics Corp's (UTHR) current share price is $307.24. This constitutes a price movement of 0.04% when compared to the ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., March 04, 2025--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that James ...